Centrica plc has announced that two of its executive directors, Christopher O'Shea and Russell O'Brien, have acquired Centrica ordinary shares under the company's Share Incentive Plan. The transactions were made on behalf of the directors by Equiniti Share Plan Trustees Limited. The details of the transactions are as follows:
- Christopher O'Shea acquired 96 partnership shares and 22 matching shares at a price of £1.5569 per share for the partnership shares and £1.51183333 per share for the matching shares. The total aggregated volume of shares acquired was 118, with a total value of £182.72. The transaction took place on October 10, 2023, on the London Stock Exchange for the partnership shares and outside a trading venue for the matching shares.
- Russell O'Brien also acquired 96 partnership shares and 22 matching shares at the same prices as Christopher O'Shea. The total aggregated volume of shares acquired was also 118, with a total value of £182.72. The transaction took place on the same date and venues as Christopher O'Shea's transaction.
Centrica plc is a listed company on the London Stock Exchange. Its registered office is located in Windsor, Berkshire, and it is registered in England & Wales under the number 3033654. The company's Legal Entity Identifier number is E26EDV109X6EEPBKVH76.